Differential requirement of PKC-θ in the development and function of natural regulatory T cells

Molecular Immunology

Volumn 46, Issue 2, 2008, Pages 213-224

  Gupta, Sonal ^a   Manicassamy, Santhakumar ^a   Vasu, Chenthamarakshan ^a   Kumar, Anvita ^b   Shang, Weirong ^c   Sun, Zuoming ^d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CD4+CD25+ cells; PKC ; Survival; T cell development

Indexed keywords

CALCINEURIN ABETA ENZYME; ESTERASE; INTERLEUKIN 2; PROTEIN BCL XL; PROTEIN KINASE C THETA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; CALCINEURIN; CELL SURVIVAL; FORKHEAD TRANSCRIPTION FACTORS; ISOENZYMES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; PROTEIN KINASE C; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

MUS;

EID: 54349086262     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.08.275     Document Type: Article

References (59)

1. Altman A., Isakov N., and Baier G. Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol. Today 21 (2000) 567-573
2. Altman A., Kaminski S., Busuttil V., Droin N., Hu J., Tadevosyan Y., Hipskind R.A., and Villalba M. Positive feedback regulation of PLCgamma1/Ca(2+) signaling by PKCtheta in restimulated T cells via a Tec kinase-dependent pathway. Eur. J. Immunol. 34 (2004) 2001-2011
3. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184 (1996) 387-396
4. Baier G. The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol. Rev. 192 (2003) 64-79
5. Baier-Bitterlich G., Uberall F., Bauer B., Fresser F., Wachter H., Grunicke H., Utermann G., Altman A., and Baier G. Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol. Cell. Biol. 16 (1996) 1842-1850
6. Barouch-Bentov R., Lemmens E.E., Hu J., Janssen E.M., Droin N.M., Song J., Schoenberger S.P., and Altman A. Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells. J. Immunol. 175 (2005) 5126-5134
7. Bueno O.F., Brandt E.B., Rothenberg M.E., and Molkentin J.D. Defective T cell development and function in calcineurin A beta-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9398-9403
8. Cabarrocas J., Cassan C., Magnusson F., Piaggio E., Mars L., Derbinski J., Kyewski B., Gross D.A., Salomon B.L., Khazaie K., et al. Foxp3+CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8453-8458
9. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., and Korsmeyer S.J. Bcl-XL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182 (1995) 821-828
10. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
11. Chow C.W., Rincon M., and Davis R.J. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell. Biol. 19 (1999) 2300-2307
12. Coudronniere N., Villalba M., Englund N., and Altman A. NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3394-3399
13. 2+, calcineurin, and NF-AT. Cell 96 (1999) 611-614
14. D'Cruz L.M., and Klein L. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6 (2005) 1152-1159
15. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., and Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172 (2004) 5149-5153
16. Fehervari Z., Yamaguchi T., and Sakaguchi S. The dichotomous role of IL-2: tolerance versus immunity. Trends Immunol. 27 (2006) 109-111
17. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
18. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
19. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., and Lafaille J.J. Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med. 196 (2002) 851-857
20. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
21. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., and Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 (1999) 5317-5326
22. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212 (2006) 256-271
23. Kriegel M.A., Li M.O., Sanjabi S., Wan Y.Y., and Flavell R.A. Transforming growth factor-beta: recent advances on its role in immune tolerance. Curr. Rheumatol. Rep. 8 (2006) 138-144
24. Li Y., Hu J., Vita R., Sun B., Tabata H., and Altman A. SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway. EMBO J. 23 (2004) 1112-1122
25. Lin X., O'Mahony A., Mu Y., Geleziunas R., and Greene W.C. Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol. Cell. Biol. 20 (2000) 2933-2940
26. Malek T.R., Yu A., Vincek V., Scibelli P., and Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17 (2002) 167-178
27. Manicassamy S., and Sun Z. The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis. J. Immunol. 178 (2007) 312-319
28. Manicassamy S., Gupta S., Huang Z., and Sun Z. Protein kinase C-{theta}-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL. J. Immunol. 176 (2006) 6709-6716
29. Manicassamy S., Sadim M., Ye R.D., and Sun Z. Differential roles of PKC-theta in the regulation of intracellular calcium concentration in primary T cells. J. Mol. Biol. 355 (2006) 347-359
30. Manicassamy S., Gupta S., Huang Z., Molkentin J.D., Shang W., and Sun Z. Requirement of calcineurin a beta for the survival of naive T cells. J. Immunol. 180 (2008) 106-112
31. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., and Schmidt-Weber C.B. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176 (2006) 3593-3602
32. Marsland B.J., Soos T.J., Spath G., Littman D.R., and Kopf M. Protein kinase C theta is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200 (2004) 181-189
33. Miyara M., and Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13 (2007) 108-116
34. Pacholczyk R., Kraj P., and Ignatowicz L. Peptide specificity of thymic selection of CD4+CD25+ T cells. J. Immunol. 168 (2002) 613-620
35. 2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197 (2003) 1525-1535
36. Saibil S.D., Jones R.G., Deenick E.K., Liadis N., Elford A.R., Vainberg M.G., Baerg H., Woodgett J.R., Gerondakis S., and Ohashi P.S. CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B. J. Immunol. 178 (2007) 2932-2939
37. Sakaguchi S. Naturally arising CD4+ regulatoryt cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
38. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
39. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., and Nomura T. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212 (2006) 8-27
40. Salek-Ardakani S., So T., Halteman B.S., Altman A., and Croft M. Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C theta. J. Immunol. 173 (2004) 6440-6447
41. Salek-Ardakani S., So T., Halteman B.S., Altman A., and Croft M. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 7635-7641
42. Schmidt-Supprian M., Tian J., Grant E.P., Pasparakis M., Maehr R., Ovaa H., Ploegh H.L., Coyle A.J., and Rajewsky K. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4566-4571
43. Setoguchi R., Hori S., Takahashi T., and Sakaguchi S. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201 (2005) 723-735
44. Shevach E.M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25 (2006) 195-201
45. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., and Thornton A.M. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol. Rev. 212 (2006) 60-73
46. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., and Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3 (2002) 135-142
47. Singh B., Read S., Asseman C., Malmstrom V., Mottet C., Stephens L.A., Stepankova R., Tlaskalova H., and Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol. Rev. 182 (2001) 190-200
48. Soper D.M., Kasprowicz D.J., and Ziegler S.F. IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur. J. Immunol. 37 (2007) 1817-1826
49. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., Annes J., Petrzilka D., Kupfer A., Schwartzberg P.L., and Littman D.R. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404 (2000) 402-407
50. Tan S.L., Zhao J., Bi C., Chen X.C., Hepburn D.L., Wang J., Sedgwick J.D., Chintalacharuvu S.R., and Na S. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 176 (2006) 2872-2879
51. Thornton A.M., and Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
52. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., and Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9 (2008) 194-202
53. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., and Ziegler S.F. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112 (2003) 1437-1443
54. Weaver C.T., Hatton R.D., Mangan P.R., and Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25 (2007) 821-852
55. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126 (2006) 375-387
56. Xie H., Huang Z., Sadim M.S., and Sun Z. Stabilized beta-catenin extends thymocyte survival by up-regulating Bcl-xL. J. Immunol. 175 (2005) 7981-7988
57. Xie H., Sadim M.S., and Sun Z. RORgammat recruits steroid receptor coactivators to ensure thymocyte survival. J. Immunol. 175 (2005) 3800-3809
58. Zhang B.W., Zimmer G., Chen J., Ladd D., Li E., Alt F.W., Wiederrecht G., Cryan J., O'Neill E.A., Seidman C.E., et al. T cell responses in calcineurin A alpha-deficient mice. J. Exp. Med. 183 (1996) 413-420
59. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature (2008)